Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Muser

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Schweizerische Medizinische Wochenschrift|October 24, 1992
[Hypoglycemia and multiple myeloma]C Merlo, C Wimpfheimer, J Muser, et al.
International Journal of Cancer|January 3, 1995
Tenascin-C in serum: an acute-phase protein or a carcinoma marker?S Schenk, J Muser, G Vollmer, et al.
Oncogene|December 1, 1989
Stimulation of pp60c-src kinase activity in FDC-P1 cells by polyoma middle-T antigen and hematopoietic growth factorsJ Muser, S Kaech, C Moroni, et al.
International Journal of Cancer|May 16, 1995
Tenascin-C in serum: a questionable tumor markerS Schenk, J Muser, G Vollmer, et al.
Die Rehabilitation|January 7, 2014
[Therapeutic nursing: a systematic review]S Lautenschläger, C Müller, U Immenschuh, et al.
Clinical Chemistry and Laboratory Medicine|August 17, 2001
Inter-laboratory evaluation of the COBAS INTEGRA 400 analytical systemJ Muser, J Bienvenu, N Blanckaert, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Schweizerische Medizinische Wochenschrift|October 24, 1992
[Hypoglycemia and multiple myeloma]C Merlo, C Wimpfheimer, J Muser, et al.
International Journal of Cancer|January 3, 1995
Tenascin-C in serum: an acute-phase protein or a carcinoma marker?S Schenk, J Muser, G Vollmer, et al.
Oncogene|December 1, 1989
Stimulation of pp60c-src kinase activity in FDC-P1 cells by polyoma middle-T antigen and hematopoietic growth factorsJ Muser, S Kaech, C Moroni, et al.
International Journal of Cancer|May 16, 1995
Tenascin-C in serum: a questionable tumor markerS Schenk, J Muser, G Vollmer, et al.
Die Rehabilitation|January 7, 2014
[Therapeutic nursing: a systematic review]S Lautenschläger, C Müller, U Immenschuh, et al.
Clinical Chemistry and Laboratory Medicine|August 17, 2001
Inter-laboratory evaluation of the COBAS INTEGRA 400 analytical systemJ Muser, J Bienvenu, N Blanckaert, et al.
Pageof 1